Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5386 to 5400 of 7681 results

  1. Effective ways of supporting women to start and continue interventions for pelvic floor dysfunction: What is the best way to support women to start and continue interventions for pelvic floor dysfunction (for example, apps, decision aids, or behavioural change techniques)?

    Recommendation ID NG210/18 Question Effective ways of supporting women to start and continue interventions for pelvic floor dysfunction:

    Research recommendation
    Published
    7 January 2022

  2. Duration of follow up: What is the clinical and cost effectiveness for different durations of follow up for people with differentiated thyroid cancer who have been treated?

    Recommendation ID NG230/02 Question Duration of follow up: What is the clinical and cost effectiveness for different durations of follow

    Research recommendation
    Published
    6 January 2023

  3. Frequency of follow-up imaging:- What is the clinical and cost effectiveness of 6-monthly imaging for 3 years for people with recurrent calcium renal or ureteric stones?

    Recommendation ID NG118/4 Question Frequency of follow-up imaging:- What is the clinical and cost effectiveness of 6-monthly imaging for

    Research recommendation
    Published
    7 March 2019

  4. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and calcium channel blockers, including compared with placebo, for adults with aortic regurgitation?

    Recommendation ID NG208/15 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  5. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with primary severe mitral regurgitation?

    Recommendation ID NG208/16 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  6. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with severe aortic stenosis?

    Recommendation ID NG208/14 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  7. Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture (including electroacupuncture) as an adjunct to aid withdrawal from opioids?

    Recommendation ID NG215/09 Question Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture

    Research recommendation
    Published
    11 May 2022

  8. Intensive rehabilitation therapies after hip fracture: What is the clinical and cost effectiveness of additional intensive physiotherapy and/or occupational therapy (for example, progressive resistance training) after hip fracture?

    Recommendation ID CG124/04 Question Intensive rehabilitation therapies after hip fracture: What is the clinical and cost effectiveness

    Research recommendation
    Published
    3 February 2023

  9. What is the clinical and cost effectiveness of a double application of antiseptic to the skin at the surgical site compared with a single application?

    Recommendation ID NG125/8 Question What is the clinical and cost effectiveness of a double application of antiseptic to the skin at the

    Research recommendation
    Published
    26 October 2020

  10. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of beta‑blockers for adults over 75 years with non‑rheumatic/calcific mitral stenosis, in both sinus rhythm and atrial fibrillation?

    Recommendation ID NG208/17 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  11. Blood pressure targets: What is the clinical and cost effectiveness of a lower blood pressure treatment target relative to the standard blood pressure treatment target for people with aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/12 Question Blood pressure targets: What is the clinical and cost effectiveness of a lower blood pressure treatment

    Research recommendation
    Published
    12 December 2022

  12. What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in adults, young people and children?

    Recommendation ID NG191/9 Question What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in

    Research recommendation
    Published
    12 November 2021

  13. What is the clinical and cost effectiveness of alternative treatments as firstline treatment for trigeminal neuralgia compared with other better-tolerated pharmacological treatments?

    Recommendation ID CG173/10 Question What is the clinical and cost effectiveness of alternative treatments as firstline treatment for trigeminal

    Research recommendation
    Published
    26 October 2020

  14. Cardiac assessment:- What is the clinical and cost effectiveness of cardiac assessment before transplantation?

    Recommendation ID NG107/1 Question Cardiac assessment:- What is the clinical and cost effectiveness of cardiac assessment before transplantation

    Research recommendation
    Published
    18 December 2018

  15. Analgesics:- What is the clinical and cost effectiveness of analgesic drugs other than non-steroidal antiinflammatory drugs (NSAIDs) in adults with rheumatoid arthritis (RA) whose pain or stiffness control is not adequate?

    Recommendation ID NG100/1 Question Analgesics:- What is the clinical and cost effectiveness of analgesic drugs other than non-steroidal

    Research recommendation
    Published
    11 December 2018